Summit Session: Alter Pharma's EU-FMD Journey with Movilitas.Cloud

Alter Pharma supplies pharmacies, wholesalers, hospitals and care homes, and parallel import adds another layer of EU-FMD complexity. At Rethink:TMRW, CIO Juan Chia shares how Movilitas.Cloud supports the company's compliance, from parallel import to product master data.

ABOUT THE SESSION

Alter Pharma Group distributes a wide range of pharmaceutical products to pharmacies, wholesalers, hospitals and retirement homes. Part of the business relies on parallel import, where products bought in one EU market are repackaged and supplied in another. Under the EU Falsified Medicines Directive, each of those packs needs correct serialization data and a clear link to the original product. In this presentation, recorded at the Rethink:TMRW Summit 2022, Juan Chia, CIO of Alter Pharma, explains why the company chose Movilitas.Cloud for EU-FMD compliance, how the platform supports its parallel import process and product master data management, and how the team plans to build on new platform capabilities.

KEY TAKEAWAYS

• Choosing a platform for EU-FMD: the reasons behind selecting a cloud-based solution for compliance.
• Parallel import in practice: handling repackaged products in a compliant, repeatable process.
• Product master data management: keeping product data consistent across markets and partners.
• What comes next: how Alter Pharma plans to extend its setup as new capabilities become available.